Company / FCF Margin
10x Genomics, Inc. FCF Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
20.2%
FY2025
5-year range
-85.2% / 20.2%
FY2021-FY2025
Trend
+2253.2%
vs FY2024
Sector context
#21 of 145
Health Care
What the data says
FCF Margin changed +2253% YoY in FY2025, a notable deviation from the 7-year average annual change of -56%.
Based on SEC 10-K filings.
20.2% in FY2025 with a 5-year CAGR of +105.4%. Top quartile in the Health Care sector.
Improved from -10.3% to 20.2% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +105.4pp
- 5-Year Change
- +105.4pp
- 10-Year Change
- -
Sector benchmark
Top 14% in Health CareTop 14% of 145This company 20.2% Sector average -207.5%
▼
+109.8% above sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s fcf margin has grown for 3 consecutive years.
- In FY2025, fcf margin increased 2253.2% year-over-year.
- Currently 227.8pp above the Health Care sector average.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 20.2% | +2253.2% |
| FY2024 | -0.9% | +90.9% |
| FY2023 | -10.3% | +87.9% |
| FY2022 | -85.2% | -2481.2% |
| FY2021 | -3.3% | +96.1% |
| FY2020 | -85.2% | -462.2% |
| FY2019 | -15.2% | - |
| FY2018 | - | - |
| FY2017 | -20.3% | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026